PSB-788
| PSB-788
|
|---|
PSB-788 is a chemical compound that acts as a selective antagonist of the adenosine A3 receptor. It is primarily used in scientific research to study the physiological and pathological roles of the adenosine A3 receptor, which is a member of the adenosine receptor family.
Pharmacology[edit]
PSB-788 is known for its high selectivity and affinity for the adenosine A3 receptor, which is one of the four subtypes of adenosine receptors, the others being A1, A2A, and A2B. The adenosine A3 receptor is involved in a variety of physiological processes, including inflammation, immune response, and cardioprotection.
Mechanism of Action[edit]
As an antagonist, PSB-788 binds to the adenosine A3 receptor and inhibits its activation by endogenous adenosine. This blockade can help elucidate the role of the A3 receptor in various biological systems and diseases. By preventing the receptor's activation, PSB-788 can modulate downstream signaling pathways that are typically activated by adenosine binding.
Therapeutic Potential[edit]
While PSB-788 itself is not used therapeutically, research involving this compound can contribute to the development of new drugs targeting the adenosine A3 receptor. Potential therapeutic areas include cancer, inflammatory diseases, and cardiovascular disorders.
Research Applications[edit]
PSB-788 is utilized in preclinical studies to explore the function of the adenosine A3 receptor in different tissues and disease models. It is often used in in vitro and in vivo experiments to assess the receptor's role in cell signaling, proliferation, and apoptosis.
Safety and Toxicology[edit]
As with many research chemicals, the safety profile of PSB-788 is not fully established. It is primarily used in controlled laboratory settings, and researchers must adhere to safety guidelines when handling the compound.
Also see[edit]
- Adenosine receptor
- Adenosine A1 receptor
- Adenosine A2A receptor
- Adenosine A2B receptor
- Receptor antagonist
| Pharmacomodulation | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian